Sarah J. Childs

Sarah J. Childs

Auto-generated profile, based on publicly available information

Sarah J. Childs

University of Calgary

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1998 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SSSandra S. Strautnieks
Sandra S. Strautnieks
LBLaura N. Bull
Laura N. Bull
AKAlexander S. Knisely
Alexander S. Knisely
SKSamuel A. Kocoshis
Samuel A. Kocoshis
NDNiklas Dahl
Niklas Dahl
RTRichard J. Thompson
Richard J. Thompson

8 November 2001 in Nature
Verified
Journal Article
Closed access
PDF file
TZTao P. Zhong
Tao P. Zhong
SCSarah Childs
Sarah Childs
JLJames P. Leu
James P. Leu
MFMark C. Fishman
Mark C. Fishman

1 January 2015 in Cell
Verified
Journal Article
Closed access
OTOwen J. Tamplin
Owen J. Tamplin
EDEllen M. Durand
Ellen M. Durand
LCLogan A. Carr
Logan A. Carr
SCSarah J. Childs
Sarah J. Childs
EHElliott J. Hagedorn
Elliott J. Hagedorn
LZLeonard I. Zon
Leonard I. Zon

1 July 2004 in Developmental Cell
Verified
Journal Article
Closed access
JTJesús Torres-Vázquez
Jesús Torres-Vázquez
AGAaron D Gitler
Aaron D Gitler
SFSherri D Fraser
Sherri D Fraser
JBJason D Berk
Jason D Berk
VPVan N. Pham
Van N. Pham
BWBrant M Weinstein
Brant M Weinstein

15 June 2002 in Development
Verified
Journal Article
Open access
PDF file
Beth RomanBeth Roman
Beth Roman
VPVan N. Pham
Van N. Pham
NLNathan D. Lawson
Nathan D. Lawson
MKMagdalena Kulik
Magdalena Kulik
SCSarah Childs
Sarah Childs
BWBrant M. Weinstein
Brant M. Weinstein
The zebrafish mutant violet beauregarde (vbg) can be identified at two days post-fertilization by an abnormal circulation pattern in which most blood cells flow through a limited number of dilated cranial vessels and fail to perfuse the trunk and tail. This phenotype cannot be explained by caudal vessel abnormalities or by a defect in cranial vessel patterning, but instead stems from an increase in endothelial cell number in specific cranial vessels. We show that vbg encodes activin receptor-like kinase 1 (Acvrl1; also known as Alk1), a TGFβ type I receptor that is expressed predominantly in the endothelium of the vessels that become dilated in vbg mutants. Thus, vbg provides a model for the human autosomal dominant disorder, hereditary hemorrhagic telangiectasia type 2, in which disruption of ACVRL1 causes vessel malformations that may result in hemorrhage or stroke. Movies available on-line

1 March 2003 in Biomaterials
Verified
Journal Article
Closed access
MDM.J. Dalby
M.J. Dalby
SCS. Childs
S. Childs
MRM.O. Riehle
M.O. Riehle
HJH.J.H. Johnstone
H.J.H. Johnstone
SAS. Affrossman
S. Affrossman
ACA.S.G. Curtis
A.S.G. Curtis